$Omega Therapeutics(OMGA.US)$ tumbled 18%, giving back some of its meteoric gains on Thursday that were driven by optimism over the clinical-stage biotechnology company's research collaboration pact with Novo Nordisk.
Omega shares almost doubled Thursday after the company said its flagship’s Pioneering Medicines initiative, and Novo Nordisk will jointly advance an obesity management program through preclinical development and...